Jim Cramer on Pfizer: “Pfizer Does Not Have Any Earnings Momentum”

Pfizer Inc. (NYSE:PFE) was one of the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not hold up in this market. A caller inquired if they should hold, sell, or buy more. In response, Cramer said:

Pfizer does not have any earnings momentum. You’re just buying it on that dividend yield of 6.66. And I’ve gotta tell you, if I want yield, I will go to bonds, not stocks.

Pfizer Inc. (NYSE:PFE) develops and sells medicines and vaccines for several health conditions, including heart disease, infections, COVID-19, and rare diseases. Cramer showed a similar sentiment toward the stock during the May 1 episode, as he commented:

Hey, can Pfizer break out of its multi-year rut? Now, a lot depends on the presentation because I haven’t seen any needle movers in the portfolio. Primarily cheap, good yield, but if I want good yield, I’ll buy a bond.

While we acknowledge the risk and potential of PFE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PFE and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.